Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology — Minneapolis, Minnesota

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology is a clinical research site located in Minneapolis, Minnesota, United States 55404.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has participated in 2 clinical trials.

Therapeutic areas: PI3K Pathway Activated Tumors, Tumor Pathway Activations Inhibited by Dovitinib.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Minneapolis

Browse all research sites in Minnesota · View every site in Minneapolis

• University of Minnesota Medical Center - Twin Cities Campus
• Minneapolis VA Call Center
• Allina Health, Abbott Northwestern Hospital, John Nasseff Neuroscience Institute
• Minneapolis Heart Institute at Abbott Northwestern Hospital
• Minneapolis VA Health Care System
• Minneapolis CC and Adult / University of Minnesota Medical Center, Fairview
• John Nasseff Neuroscience Institute - Abott Northwestern Hospital
• University of Minnesota, Department of Neurosurgery
• University of Minnesota, Program in Physical Therapy
• University of Minnesota/VA Medical Center
• University of Minnesota School of Nursing
• University of Minnesota /ID# 1140-0807

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology?

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology conducted?

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has 2 clinical trials on record. Their work covers PI3K Pathway Activated Tumors, Tumor Pathway Activations Inhibited by Dovitinib.

Is Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology accredited by Crixeo Clinical Trials?

Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Minnesota Oncology Hematology, P.A. Minnesota Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.